Back to search

Article

CD155/PVR as a determinant of anti-HER2 therapy sensitivity in breast cancer

2025-11-14

Abstract excerpt

<title>Abstract</title> <p> CD155 (poliovirus receptor, PVR) is frequently overexpressed across cancers and has been associated with tumor progression, poor prognosis, and therapy resistance. Here, we identify CD155 as a modulator of HER2-targeted monoclonal antibody efficacy. Analysis of clinical datasets revealed that high CD155 expression correlates with overall, progression-free, and disease-specific surviva...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
48ec52a6-580c-587f-95d8-9ff3a2413a01
DOI
10.21203/rs.3.rs-7994408/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD155/PVR as a determinant of anti-HER2 therapy sensitivity in breast cancerDOI 10.21203/rs.3.rs-7994408/v1
Select a neighboring publication to make it the new centre.